Changes of HCV quasispecies during combination therapy with interferon and ribavirin

Hepatology Research

Volumn 29, Issue 2, 2004, Pages 89-96

  Ueda, Eri ^a   Enomoto, Nobuyuki ^a   Sakamoto, Naoya ^a   Hamano, Kosei ^a   Sato, Chifumi ^a   Izumi, Namiki ^b   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b MUSASHINO RED CROSS HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; Hypervariable region (HVR); Interferon (IFN); Interferon sensitivity determining region (ISDR); Quasispecies; Ribavirin

Indexed keywords

ALPHA2B INTERFERON; NUCLEOTIDE; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MOLECULAR CLONING; MONOTHERAPY; PRIORITY JOURNAL; SPECIES DIVERSITY; TREATMENT FAILURE; TREATMENT OUTCOME; VIROLOGY;

EID: 2442671740     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.02.014     Document Type: Article

References (32)

1. Choo Q.L. Kuo G. Weiner A.J. Overby L.R. Bradley D.W. Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359-362
2. Hoofnagle J.H. Course and outcome of hepatitis C Hepatology 36 2002 S21-S29
3. Di Bisceglie A.M. Hoofnagle J.H. Optimal therapy of hepatitis C Hepatology 36 2002 S121-S127
4. Chander G. Sulkowski M.S. Jenckes M.W. et al. Treatment of chronic hepatitis C: a systematic review Hepatology 36 2002 S135-S144
5. Lau J.Y. Tam R.C. Liang T.J. Hong Z. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection Hepatology 35 2002 1002-1009
6. Cramp M.E. Rossol S. Chokshi S. Carucci P. Williams R. Naoumov N.V. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C Gastroenterology 118 2000 346-355
7. Kamal S.M. Fehr J. Roesler B. Peters T. Rasenack J.W. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C Gastroenterology 123 2002 1070-1083
8. Lee J.H. von Wagner M. Roth W.K. Teuber G. Sarrazin C. Zeuzem S. Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus J. Hepatol. 29 1998 29-35
9. Zeuzem S. Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy Forum (Genova) 10 2000 32-42
10. Hu K.Q. Vierling J.M. Redeker A.G. Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection J. Viral. Hepat. 8 2001 1-18
11. Maag D. Castro C. Hong Z. Cameron C.E. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin J. Biol. Chem. 276 2001 46094-46098
12. Crotty S. Cameron C.E. Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin Proc. Natl. Acad. Sci. U.S.A. 98 2001 6895-6900
13. Eigen M. Error catastrophe and antiviral strategy Proc. Natl. Acad. Sci. U.S.A. 99 2002 13374-13376
14. Graci J.D. Cameron C.E. Quasispecies, error catastrophe, and the antiviral activity of ribavirin Virology 298 2002 175-180
15. Forns X. Purcell R.H. Bukh J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus Trends Microbiol. 7 1999 402-410
16. Gomez J. Martell M. Quer J. Cabot B. Esteban J.I. Hepatitis C viral quasispecies J. Viral. Hepat. 6 1999 3-16
17. Farci P. Purcell R.H. Clinical significance of hepatitis C virus genotypes and quasispecies Semin. Liver Dis. 20 2000 103-126
18. Enomoto N. Sakuma I. Asahina Y. et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection N. Engl. J. Med. 334 1996 77-81
19. Polyak S.J. Gerotto M. The molecular basis for responsiveness to anti-viral therapy in hepatitis C Forum (Genova) 10 2000 46-58
20. Tan S.L. Katze M.G. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A Virology 284 2001 1-12
21. Katze M.G. He Y. Gale M. Jr Viruses and interferon: a fight for supremacy Nat. Rev. Immunol. 2 2002 675-687
22. He Y. Katze M.G. To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon Viral Immunol. 15 2002 95-119
23. Kato N. Hijikata M. Ootsuyama Y. et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis Proc. Natl. Acad. Sci. U.S.A. 87 1990 9524-9528
24. Thompson J.D. Higgins D.G. Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucl. Acids Res. 22 1994 4673-4680
25. Lyra A.C. Fan X. Lang D.M. et al. Evolution of hepatitis C viral quasispecies after liver transplantation Gastroenterology 123 2002 1485-1493
26. Ciurea A. Klenerman P. Hunziker L. et al. Viral persistence in vivo through selection of neutralizing antibody-escape variants Proc. Natl. Acad. Sci. U.S.A. 97 2000 2749-2754
27. Polyak S.J. McArdle S. Liu S.L. et al. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection J. Virol. 72 1998 4288-4296
28. Farci P. Strazzera R. Alter H.J. et al. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome Proc. Natl. Acad. Sci. U.S.A. 99 2002 3081-3086
29. Witherell G.W. Beineke P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response J. Med. Virol. 63 2001 8-16
30. Querenghi F. Yu Q. Billaud G. Maertens G. Trepo C. Zoulim F. Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy J. Viral. Hepat. 8 2001 120-131
31. Sookoian S. Castano G. Frider B. Cello J. Campos R. Flichman D. Combined therapy with interferon and ribavirin in chronic hepatitis C does not affect serum quasispecies diversity Dig. Dis. Sci. 46 2001 1067-1071
32. Gerotto M. Sullivan D.G. Polyak S.J. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C J. Virol. 73 1999 7241-7247